Reaction
Greater Trochanteric Pain Syndrome reporting signals
As of the last recalculation, Greater Trochanteric Pain Syndrome appears in 188 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is CLOBETASOL PROPIONATE OINTMENT USP, 0.05% (PRR 101.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Clobetasol Propionate Ointment Usp, 0.05% | 9 | 101.6 | 101.7 |
| Clobetasol Propionate | 9 | 101.1 | 101.2 |
| Felodipine Extended-Release Tablets | 8 | 81.2 | 81.2 |
| Felodipine | 8 | 81.2 | 81.2 |
| Cannabidiol | 13 | 66.0 | 66.0 |
| Voclosporin | 3 | 38.8 | 38.9 |
| Alpelisib | 3 | 38.7 | 38.7 |